President Donald Trump speaks at a Nov. 20 news conference in the briefing room at the White House (Susan Walsh/AP)
December 7, 2020 04:28 PM ESTUpdated December 8, 09:41 AM
Coronavirus

Covid-19 roundup: Pfiz­er and Mod­er­na won't at­tend White House­'s 'Vac­cine Sum­mit' — re­port; Sino­vac clar­i­fies ef­fi­ca­cy num­bers

Max Gelman

Senior Editor

Though the White House is plan­ning on host­ing a “Vac­cine Sum­mit” on Tues­day, two ma­jor play­ers will not be at­tend­ing.

Pfiz­er and Mod­er­na have both …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sen­ate Ju­di­cia­ry Com­mit­tee ad­vances patent bill with new pro­tec­tions for phar­ma chal­lenges

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

A service from the Financial Times